Palliative inpatient chemotherapy: Clinical benefit or harm?

被引：0
|
作者：
Ali, Maria
Cripps, M. Christine
Balchin, Katelyn
Spencer, Jennifer
Wheatley-Price, Paul
机构：
[1] Univ Ottawa, Postgrad Med Educ, Ottawa, ON, Canada
[2] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[3] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
[4] Ottawa Hosp Canc Ctr, Div Pharm, Ottawa, ON, Canada
[5] Univ Ottawa, Dept Med, Ottawa Hosp Canc Ctr, Div Med Oncol, Ottawa, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19527
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The duty to recontact: Benefit and harm
    Sharpe, NF
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : 1201 - 1204
  • [32] Antibiotics in the ICU; benefit or harm?
    James C. Hurley
    Intensive Care Medicine, 2020, 46 : 1798 - 1799
  • [33] Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients
    Tsubamoto, Hiroshi
    Ito, Yoshihiro
    Kanazawa, Riichiro
    Wada, Ryu
    Hosoda, Yoko
    Honda, Okuto
    Takeyama, Ryu
    Sakane, Riya
    Wakimoto, Yu
    Shibahara, Hiroaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (05) : 1399 - 1406
  • [34] ADJUVANT CHEMOTHERAPY IN STAGE-I BREAST-CANCER - MORE HARM THAN BENEFIT
    MUELLER, CB
    CANADIAN FAMILY PHYSICIAN, 1993, 39 : 2185 - 2189
  • [35] BENEFIT OF PALLIATIVE CHEMOTHERAPY AND HOSPICE ENROLLMENT IN LATE-STAGE OVARIAN CANCER PATIENTS
    Kato, T.
    Tsubamoto, H.
    Ukita, Y.
    Shibahara, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [36] Polypharmacy: Scales of benefit and harm?
    Gudmundsson, Adalsteinn
    LAEKNABLADID, 2023, 109 (10): : 435 - 435
  • [37] Clinical benefit from palliative chemotherapy in non-small cell lung cancer extends to the elderly and those with poor prognostic factors
    Hickish, TF
    Smith, IE
    O'Brien, MER
    Ashley, S
    Middleton, G
    BRITISH JOURNAL OF CANCER, 1998, 78 (01) : 28 - 33
  • [38] Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors
    TF Hickish
    IE Smith
    MER O'Brien
    S Ashley
    G Middleton
    British Journal of Cancer, 1998, 78 : 28 - 33
  • [39] Screening for Asymptomatic Carotid Artery Stenosis Lack of Clinical Benefit, Potential for Harm
    Goldstein, Larry B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (05): : 443 - 444
  • [40] Clinical benefit of palliative treatment of cancer cachexia with medroxyprogesterone acetate (MPA)
    Tassinari, D
    Flamini, E
    Poggi, B
    Fochessati, F
    Fantini, M
    Fabbri, L
    Turci, P
    Monti, F
    Polselli, A
    Maltoni, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 782S - 782S
12345